Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
Cancer Immunology, Immunotherapy : CII|January 27, 2016
Selection and expansion of natural killer cells for NK cell-based immunotherapyPetra S A Becker, Garnet Suck, Paulina Nowakowska, et al.
Cardiology in the Young|February 15, 2012
Intracoronary bone marrow cell application for terminal heart failure in childrenStefan Rupp, Christian Jux, Halvard Bönig, et al.
Cancer Immunology, Immunotherapy : CII|September 8, 2017
Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignanciesPaulina Nowakowska, Annette Romanski, Nicole Miller, et al.
The Journal of Investigative Dermatology|April 26, 2003
Allelic variants of drug metabolizing enzymes as risk factors in psoriasisDagmar Richter-Hintz, Ricarda Their, Swantje Steinwachs, et al.
Cancer Immunology, Immunotherapy : CII|August 25, 2007
Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cellsTina Müller, Christoph Uherek, Guitta Maki, et al.
Cytotherapy|July 13, 2024
Characterization of immortalized bone marrow erythroid progenitor adult (imBMEP-A)-The first inducible immortalized red blood cell progenitor cell line derived from bone marrow CD71-positive cellsRomy Kronstein-Wiedemann, Jessica Thiel, Duran Sürün, et al.
Iscience|March 9, 2026
From byproduct to biotherapeutic: Comparative study of buffy coats and leukoreduction system chambers for NK cell-based immunotherapiesMaximiliane Tietze, Maria Schuldt, Martina Wohsmann, et al.
Leukemia|February 28, 2023
Novel evidence that the ABO blood group shapes erythropoiesis and results in higher hematocrit for blood group B carriersRomy Kronstein-Wiedemann, Sarah Blecher, Madeleine Teichert, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantationUlrike Koehl, Jan Sörensen, Ruth Esser, et al.
Blood|October 28, 2011
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in micePeter Milanov, Lacramioara Ivanciu, Daniela Abriss, et al.
Pageof 14